Literature DB >> 4143704

Hypertension, diabetes mellitus, and blood groups in benign prostatic hypertrophy.

J B Bourke, J P Griffin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 4143704     DOI： 10.1111/j.1464-410x.1966.tb09675.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN： 0007-1331


× No keyword cloud information.
  22 in total

1.  Prostate volume correlates with diabetes in elderly benign prostatic hyperplasia patients.

Authors:  Xiaobing Qu; Zhichao Huang; Xianqin Meng; Xiangyu Zhang; Lini Dong; Xiaokun Zhao
Journal:  Int Urol Nephrol       Date:  2014-03       Impact factor: 2.370

2.  Diabetes mellitus and prostatic hyperplasia.

Authors:  J B Bourke; J P Griffin
Journal:  Br Med J       Date:  1968-12-28

3.  Examining the enlarged prostate.

Authors: 
Journal:  Br Med J       Date:  1969-06-07

Review 4.  PPARγ: a molecular link between systemic metabolic disease and benign prostate hyperplasia.

Authors:  Ming Jiang; Douglas W Strand; Omar E Franco; Peter E Clark; Simon W Hayward
Journal:  Differentiation       Date:  2011-06-08       Impact factor: 3.880

5.  Diabetes associated with prostatic hypertophy and its managemnet in transvesical prostatectomy.

Authors:  G Y Corradi; F Fürst; E Korányi; L Hazay
Journal:  Int Urol Nephrol       Date:  1974       Impact factor: 2.370

6.  A morphological study of the prostatic lobes and the seminal vesicles of castrated rats injected with oestradiol and/or insulin.

Authors:  L E Tisell; H Andersson; L Angervall
Journal:  Urol Res       Date:  1976-07-23

7.  Prostate angiogenesis in development and inflammation.

Authors:  Letitia Wong; Jerry Gipp; Jason Carr; Christopher J Loftus; Molly Benck; Sanghee Lee; Vatsal Mehta; Chad M Vezina; Wade Bushman
Journal:  Prostate       Date:  2013-11-30       Impact factor: 4.104

8.  Diabetes mellitus in patients with benign prostatic hyperplasia.

Authors:  J B Bourke; J P Griffin
Journal:  Br Med J       Date:  1968-11-23

9.  Polyamines, hydrolases, (PAP, LAP, SDH, plasmin) TSH, T3, T4 and C-peptide in benign hyperplasia of the prostate.

Authors:  U Dunzendorfer; W Weber; D H Russell
Journal:  Urol Res       Date:  1981

10.  The impact of diabetes type 2 in the pathogenesis of benign prostatic hyperplasia: a review.

Authors:  K Stamatiou; M Lardas; E Kostakos; V Koutsonasios; E Michail
Journal:  Adv Urol       Date:  2009-11-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.